A D Roth - JoVE Visualize

Showing results (1-10 of 37) with videos related to

Pageof 4

Sort By:

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2003

Docetaxel-based chemotherapy in the treatment of gastric cancerA D Roth, J Ajani

Natural Immunity and Cell Growth Regulation|January 1, 1989

New clinical trials with interleukin-2: rationale for regional administrationA D Roth, J M Kirkwood

The British Journal of Clinical Psychology|May 1, 1994

The use of revised habituation in the treatment of obsessive-compulsive disordersA D Roth, J A Church

Acta Oncologica (Stockholm, Sweden)|July 31, 1999

High dose etretinate and interferon-alpha--a phase I study in squamous cell carcinomas and transitional cell carcinomasA D Roth, R Morant, P Alberto

Clinical and Experimental Immunology|August 1, 1995

Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cellsA D Roth, S Dupuis, P Alberto

Oncology|January 1, 1994

13-cis-retinoic acid plus interferon-alpha: a phase II clinical study in squamous cell carcinoma of the lung and the head and neckA D Roth, R Abele, P Alberto

Revue Medicale Suisse|July 5, 2011

[Targeted therapies in digestive oncology]M-L Amram, D A Benamran, A D Roth

The British Journal of Surgery|October 22, 1998

Results of surgical resection of liver metastases from non-colorectal primariesT Berney, G Mentha, A D Roth, et al.

Diseases of the Colon and Rectum|November 11, 2006

Complete closure of cancer-related anovaginal and anoperineal fistulas in locally advanced anal canal carcinomas by upfront intra-arterial chemotherapy followed by combined radiochemotherapy: report of two casesL Rosset, A S Allal, P Morel, et al.

Clinical and Experimental Immunology|October 1, 1991

Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanomaA D Roth, F J Hornicek, C G Gerstner, et al.

Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:

Pageof 4

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2003

Docetaxel-based chemotherapy in the treatment of gastric cancerA D Roth, J Ajani

Natural Immunity and Cell Growth Regulation|January 1, 1989

New clinical trials with interleukin-2: rationale for regional administrationA D Roth, J M Kirkwood

The British Journal of Clinical Psychology|May 1, 1994

The use of revised habituation in the treatment of obsessive-compulsive disordersA D Roth, J A Church

Acta Oncologica (Stockholm, Sweden)|July 31, 1999

High dose etretinate and interferon-alpha--a phase I study in squamous cell carcinomas and transitional cell carcinomasA D Roth, R Morant, P Alberto

Clinical and Experimental Immunology|August 1, 1995

Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cellsA D Roth, S Dupuis, P Alberto

Oncology|January 1, 1994

13-cis-retinoic acid plus interferon-alpha: a phase II clinical study in squamous cell carcinoma of the lung and the head and neckA D Roth, R Abele, P Alberto

Revue Medicale Suisse|July 5, 2011

[Targeted therapies in digestive oncology]M-L Amram, D A Benamran, A D Roth

The British Journal of Surgery|October 22, 1998

Results of surgical resection of liver metastases from non-colorectal primariesT Berney, G Mentha, A D Roth, et al.

Diseases of the Colon and Rectum|November 11, 2006

Complete closure of cancer-related anovaginal and anoperineal fistulas in locally advanced anal canal carcinomas by upfront intra-arterial chemotherapy followed by combined radiochemotherapy: report of two casesL Rosset, A S Allal, P Morel, et al.

Clinical and Experimental Immunology|October 1, 1991

Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanomaA D Roth, F J Hornicek, C G Gerstner, et al.

Pageof 4